Furthermore, SHE administration can ameliorate cognitive impairment caused by SCO by enhancing neuron survival and synaptic plasticity through the activation of the ERK/CREB/BDNF and PI3K/Akt/GSK-3β signaling pathways in mouse hippocampus. Here, AKT1 is linked to Cognitive impairment.